162 related articles for article (PubMed ID: 15781334)
21. In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cells.
Rigolin GM; Porta MD; Ciccone M; Bugli AM; Bragotti LZ; Mauro E; Fraulini C; Rossi AR; Bardi A; Cuneo A; Castoldi G
Br J Haematol; 2004 Aug; 126(4):501-7. PubMed ID: 15287942
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
23. [Effect of IL-15 on the proliferation and differentiation of CD34+ cells from MDS patients].
Ye ZL; Chen MZ; Chen RL; Cheng WM; Huang XL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):106-9. PubMed ID: 15629097
[TBL] [Abstract][Full Text] [Related]
24. Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting.
Miura I; Takahashi N; Kobayashi Y; Saito K; Miura AB
Int J Hematol; 2000 Oct; 72(3):310-7. PubMed ID: 11185986
[TBL] [Abstract][Full Text] [Related]
25. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
26. In vitro functional defects of bone marrow-derived CD34+ progenitors from newly diagnosed mature B-cell malignancies with bone marrow tumor involvement.
Amé-Thomas P; Deschaseaux F; Mauny F; Bulabois CE; Lamy T; Hervé P; Cahn JY; Fest T
Exp Hematol; 2005 Mar; 33(3):318-28. PubMed ID: 15730855
[TBL] [Abstract][Full Text] [Related]
27. Characterization of bone marrow stromal abnormalities in a patient with constitutional trisomy 8 mosaicism and myelodysplastic syndrome.
Narendran A; Hawkins LM; Ganjavi H; Vanek W; Gee MF; Barlow JW; Johnson G; Malkin D; Freedman MH
Pediatr Hematol Oncol; 2004; 21(3):209-21. PubMed ID: 15202160
[TBL] [Abstract][Full Text] [Related]
28. Expansive effects of aorta-gonad-mesonephros-derived stromal cells on hematopoietic stem cells from embryonic stem cells.
Fu JR; Liu WL; Zhou YF; Zhou JF; Sun HY; Luo L; Zhang H; Xu HZ
Chin Med J (Engl); 2005 Dec; 118(23):1979-86. PubMed ID: 16336834
[TBL] [Abstract][Full Text] [Related]
29. Distinct signal transduction abnormalities and erythropoietin response in bone marrow hematopoietic cell subpopulations of myelodysplastic syndrome patients.
Spinelli E; Caporale R; Buchi F; Masala E; Gozzini A; Sanna A; Sassolini F; Valencia A; Bosi A; Santini V
Clin Cancer Res; 2012 Jun; 18(11):3079-89. PubMed ID: 22496271
[TBL] [Abstract][Full Text] [Related]
30. Significance of CD34(-) and CD34(+) cell apoptosis and proliferation in bone marrow of patients with MDS and their impact on survival.
Xia B; Guo Q; Zhao DD; Zhao HF; Han XP; Wang H; Wu XX; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1392-7. PubMed ID: 23257440
[TBL] [Abstract][Full Text] [Related]
31. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
[TBL] [Abstract][Full Text] [Related]
32. [The role of hematopoietic growth factors on extensive apoptosis of myelodysplastic hematopoietic cells and its clinical significance].
Cao Z; Li R; Li Q
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):27-30. PubMed ID: 10921099
[TBL] [Abstract][Full Text] [Related]
33. Fas/Fas-ligand expressions in peripheral-blood mononuclear cells of patients with myelodysplastic syndromes.
Hirano T; Hiratsuka N; Iwahori T; Oka K; Wakasugi K
Res Commun Mol Pathol Pharmacol; 2003; 113-114():315-28. PubMed ID: 15686130
[TBL] [Abstract][Full Text] [Related]
34. In vitro hemopoiesis of marrow cells from myelodysplastic patients: effects of mitogen-stimulated spleen cell-conditioned medium and vitamin A and D derivatives.
Fabian I; Riklis I; Tatarsky I; Nagler A
Cancer Res; 1986 May; 46(5):2596-9. PubMed ID: 3697999
[TBL] [Abstract][Full Text] [Related]
35. Identification of defects in the transcriptional program during lineage-specific in vitro differentiation of CD34(+) cells selected from patients with both low- and high-risk myelodysplastic syndrome.
Gueller S; Komor M; Nowak D; Baldus CD; de Vos S; Hoelzer D; Ottmann OG; Hofmann WK
Exp Hematol; 2010 Sep; 38(9):718-32, 732.e1-6. PubMed ID: 20621626
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
Saitoh K; Miura I; Takahashi N; Miura AB
Blood; 1998 Oct; 92(8):2886-92. PubMed ID: 9763574
[TBL] [Abstract][Full Text] [Related]
37. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells.
Sawada K; Sato N; Notoya A; Tarumi T; Hirayama S; Takano H; Koizumi K; Yasukouchi T; Yamaguchi M; Koike T
Blood; 1995 Jan; 85(1):194-202. PubMed ID: 7528567
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypic analysis of myelodysplastic syndromes.
Del Cañizo MC; Fernández ME; López A; Vidriales B; Villarón E; Arroyo JL; Ortuño F; Orfao A; San Miguel JF
Haematologica; 2003 Apr; 88(4):402-7. PubMed ID: 12681967
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
[TBL] [Abstract][Full Text] [Related]
40. Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks.
Moroz C; Grunspan A; Zahalka MA; Traub L; Kodman Y; Yaniv I
Exp Hematol; 2006 Feb; 34(2):159-66. PubMed ID: 16459184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
